Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CG✓SelectedUSD · CGMRNA vs CG performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs CG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+948.4%
CG return
+169.9%
Excess return
+778.5%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCGExcessAlpha
1D-2.2%-4.4%+2.3%-0.7%
7D-12.7%-8.7%-4.0%-10.0%
30D-20.7%-2.5%-18.1%-20.0%
3M+46.3%-24.3%+70.6%+60.2%
6M+305.2%-19.3%+324.5%+335.6%
YTD+561.2%-37.3%+598.5%+665.4%
1Y+772.1%-27.0%+799.1%+866.0%
3Y+147.0%+23.3%+123.7%+139.5%
5Y-26.1%-28.0%+1.9%-27.1%
All+948.4%+169.9%+778.5%+845.0%

Cumulative growth

Daily Returns

Daily percentage return beside CG.

Daily Out/Under-Performance

Portfolio return minus CG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling